After Peaking at $6.3 Billion in 2011, Generic Erosion of Atypical Antipsychotics Will Cause the Schizophrenia Drug Market to Decline to $5.2 Billion in 2019
Advertisement
The Launch of Depot Formulations of Atypical Antipsychotics Will Partially Offset Losses in the Market, According to Findings from Decision Resources